Assfalg-Machleidt I, Billing A, Fröhlich D, Nast-Kolb D, Joka T, Jochum M, Machleidt W
Institut für Physiologische Chemie, Physikalische Biochemie und Zellbiologie, Universität München, Germany.
Agents Actions Suppl. 1992;38 ( Pt 1):312-21. doi: 10.1007/978-3-0348-7321-5_40.
The contribution of the kininogens and cystatin C to the functional inhibitory capacity for cysteine proteinases of blood plasma and inflammatory secretions was estimated from ex vivo experiments. 98.5% of the inhibitory capacity of blood plasma for cathepsin L (4-5 microM) is provided by the kininogens ensuring a complete control of this enzyme even at a lowered kininogen concentration. Control of cathepsin B activity by the kininogens is incomplete and depends critically on the active concentration of cystatin C (70 nM in normal plasma), which is reduced in blood plasma of polytraumatized and septic patients and very low in epithelial lining fluid of the shock lung.
通过体外实验评估了激肽原和胱抑素C对血浆和炎性分泌物中半胱氨酸蛋白酶的功能抑制能力。血浆对组织蛋白酶L(4 - 5微摩尔)的抑制能力的98.5%由激肽原提供,即使在激肽原浓度降低时也能确保对该酶的完全控制。激肽原对组织蛋白酶B活性的控制是不完全的,并且严重依赖于胱抑素C的活性浓度(正常血浆中为70纳摩尔),在多发伤和脓毒症患者的血浆中该浓度降低,在休克肺的上皮衬液中则非常低。